Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
8.29
+1.07 (14.82%)
At close: Aug 20, 2026, 4:00 PM EDT
8.30
+0.01 (0.12%)
Pre-market: Aug 21, 2026, 5:19 AM EDT

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $51.44M in the quarter ending June 30, 2026, with 8.53% growth. This brings the company's revenue in the last twelve months to $208.78M, down -5.03% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%.

Revenue (ttm)
$208.78M
Revenue Growth
-5.03%
P/S Ratio
10.31
Revenue / Employee
$503,072
Employees
415
Market Cap
2.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.